What is the most recent earnings date for GOSS stock?
GOSSAMER BIO INC (GOSS) last reported earnings on 3/17/2026.
GOSSAMER BIO INC (GOSS) Earnings History & Surprises
NASDAQ:GOSS • US38341P1021
Current stock price
0.4095 USD
+0.04 (+10.2%)
At close:
0.3928 USD
-0.02 (-4.08%)
After Hours:
GOSS Earnings overview
Past quarterly earnings results for GOSSAMER BIO INC (GOSS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.18
- Revenue Estimate
- 4.804M
Last Reported
Most Recent- Release Date
- Mar 17, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.21
- EPS Surprise
- -5.22%
- Revenue Surprise
- 79.84%
Beat Rate
Last 8 Quarters 31%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.21 | -0.20 | -5.22% | -40.00% | 13.799M | 7.673M | 79.84% | 47.13% |
| Q3 2025 | -0.21 | -0.20 | -7.37% | -50.00% | 13.294M | 6.457M | 105.89% | 40.23% |
| Q2 2025 | -0.17 | -0.18 | 7.97% | -177.27% | 11.489M | 4.426M | 159.58% | -88.01% |
| Q1 2025 | -0.16 | -0.19 | 16.34% | 15.79% | 9.889M | 4.149M | 138.35% | - |
| Q4 2024 | -0.15 | -0.17 | 13.49% | 28.57% | 9.379M | 6.971M | 34.54% | - |
| Q3 2024 | -0.14 | -0.15 | 7.13% | 33.33% | 9.48M | 7.854M | 20.70% | - |
| Q2 2024 | 0.22 | 0.23 | -5.81% | 148.89% | 95.842M | 116.57M | -17.78% | - |
| Q1 2024 | -0.19 | -0.19 | 1.50% | 63.46% | - | - | ||
| Q4 2023 | -0.21 | -0.21 | 0.96% | 64.41% | - | - | ||
| Q3 2023 | -0.21 | -0.26 | 19.45% | 67.69% | - | - | ||
| Q2 2023 | -0.45 | -0.50 | 9.78% | 39.19% | - | - | ||
| Q1 2023 | -0.52 | -0.54 | 3.74% | 31.58% | - | - | ||
| Q4 2022 | -0.59 | -0.64 | 7.17% | 20.27% | - | - | ||
| Q3 2022 | -0.65 | -0.65 | -0.34% | 18.75% | - | - | ||
| Q2 2022 | -0.74 | -0.71 | -3.72% | 7.50% | - | - | ||
| Q1 2022 | -0.76 | -0.78 | 2.81% | 2.56% | - | - | ||
| Q4 2021 | -0.74 | -0.76 | 2.40% | 15.91% | - | - | ||
| Q3 2021 | -0.80 | -0.80 | 0.09% | - | - | - | ||
| Q2 2021 | -0.80 | -0.77 | -3.54% | 20.00% | - | - | ||
| Q1 2021 | -0.78 | -0.77 | -1.62% | 10.34% | - | - | ||
| Q4 2020 | -0.88 | -0.81 | -9.21% | - | - | - | ||
| Q3 2020 | -0.80 | -0.87 | 8.09% | - | - | - | ||
| Q2 2020 | -1.00 | -0.88 | -13.56% | - | - | - | ||
| Q1 2020 | -0.87 | -0.82 | -6.62% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
2.93%
Max EPS beat (4)
16.34%
Min EPS beat (4)
-7.37%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
120.91%
Max Revenue beat (4)
159.58%
Min Revenue beat (4)
79.84%
Analysis
In the last 4 quarters, GOSS has beaten EPS estimates in 2 out of 4 releases
GOSS has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, GOSS has beaten the EPS estimates by 2.9% on average.
In the last 4 quarters, GOSS has beaten the revenue estimates by 120.9% on average.
Related analysis
GOSSAMER BIO INC / GOSS Earnings FAQ
Did GOSS stock beat earnings estimates in the most recent quarter?
GOSSAMER BIO INC (GOSS) missed EPS estimates and beat revenue estimates in the most recent quarter.
How often does GOSSAMER BIO INC (GOSS) beat earnings estimates?
In the last 4 quarters, GOSSAMER BIO INC (GOSS) has beaten EPS estimates in 2 out of 4 releases.